Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POMINC: Ruxolitinib and Pomalidomide in Myelofibrosis
NCT01644110Phase 2Completed
- Sponsor
- Ulm University
- Start
- Aug 2013
- Primary completion
- Apr 2024
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in myelofibrosis (MF), sponsored by Ulm University. Started Aug 2013; status: completed.
02
Drugs
pomalidomide
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT01644110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01644110.